| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.06▲ | 4.06▲ | 4.08▲ | 4.18▼ | 4.33▼ |
| MA10 | 4.09▲ | 4.14▲ | 4.19▲ | 4.37▼ | 4.53▼ |
| MA20 | 4.23▼ | 4.30▼ | 4.33▼ | 4.37▼ | 4.63▼ |
| MA50 | 4.42▼ | 4.35▼ | 4.29▼ | 4.61▼ | 13.29▼ |
| MA100 | 4.29▼ | 4.39▼ | 4.47▼ | 4.69▼ | 293.99▼ |
| MA200 | 4.48▼ | 4.62▼ | 4.71▼ | 10.52▼ | 389.43▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.001▼ | -0.022▼ | -0.037▼ | -0.030▼ | 3.142▲ |
| RSI | 47.168▼ | 45.910▼ | 45.576▼ | 41.345▼ | 34.326▼ |
| STOCH | 30.918 | 30.918 | 21.361 | 22.363 | 28.542 |
| WILL %R | -20.290▲ | -58.015 | -58.015 | -74.372 | -78.417▼ |
| CCI | 40.082 | -11.869 | -39.732 | -121.803▼ | -150.892▼ |
|
Monday, July 27, 2026 05:05 AM
Filing supports potential development of radiopharmaceuticals, T-cell engagers and other immune-based approaches using a versatile platform approach SEATTLE, WA / ACCESS Newswire / July 27, 2026 / ...
|
|
Tuesday, June 16, 2026 02:15 AM
We are initiating coverage of Aptevo Therapeutics Inc. (NASDAQ: APVO) with a valuation of $30.00. Aptevo is a clinical-stage biotechnology company developing multispecific immunotherapies designed to ...
|
|
Wednesday, January 14, 2026 03:09 AM
The average one-year price target for Aptevo Therapeutics (NasdaqCM:APVO) has been revised to $7,711.20 / share. This is an increase of 1,700.00% from the prior estimate of $428.40 dated December 18, ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/07/26 | 4.085 | 4.21 | 3.90 | 4.13 | 11,176 |
| 29/07/26 | 4.20 | 4.215 | 3.945 | 3.98 | 22,251 |
| 28/07/26 | 4.21 | 4.3399 | 4.17 | 4.21 | 7,902 |
| 27/07/26 | 4.45 | 4.45 | 4.1684 | 4.21 | 37,978 |
| 24/07/26 | 4.3017 | 4.42 | 4.2813 | 4.39 | 2,148 |
| 23/07/26 | 4.37 | 4.58 | 4.37 | 4.37 | 18,603 |
| 22/07/26 | 4.42 | 4.5216 | 4.395 | 4.45 | 18,396 |
| 21/07/26 | 4.61 | 4.61 | 4.38 | 4.42 | 26,501 |
| 20/07/26 | 4.86 | 4.86 | 4.6028 | 4.755 | 26,452 |
| 17/07/26 | 4.34 | 4.87 | 4.26 | 4.74 | 32,844 |
|
|
||||
|
|
||||
|
|